Public Market Trends in Ophthalmology

Andrew Gitkin, head of West Coast biotechnology investment banking at Piper Jaffray, examines first-half performance of critical markets. Also, what impact is Washington’s intransigence having on the markets? And what does this all mean for the healthcare market?